Use access key #2 to skip to page content.
$43.56 1.11 (2.61%)
5/16/2008 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar deuspecuniae (24.57) Submitted: 5/01/08 12:11 PM : Outperform Start Price: $41.47 AZN Score: 2.86

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Report this Post Replies: 0 | Reply

Featured Broker Partners